64 related articles for article (PubMed ID: 34237057)
1. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
[TBL] [Abstract][Full Text] [Related]
2. The role of galanin in the progression and prognosis of colorectal cancer: the unfinished story.
Kmiec Z; Kieżun J; Krazinski BE; Kwiatkowski P; Godlewski J
Eur J Histochem; 2024 Mar; 68(1):. PubMed ID: 38568200
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of the
Wu B; Zhou Q; He Z; Wang X; Sun X; Chen Y
Evid Based Complement Alternat Med; 2021; 2021():7422792. PubMed ID: 34408782
[TBL] [Abstract][Full Text] [Related]
4. Metformin intervention ameliorates AS in ApoE-/- mice through restoring gut dysbiosis and anti-inflammation.
Yan N; Wang L; Li Y; Wang T; Yang L; Yan R; Wang H; Jia S
PLoS One; 2021; 16(7):e0254321. PubMed ID: 34264978
[TBL] [Abstract][Full Text] [Related]
5. Musashi-2 (MSI2) regulation of DNA damage response in lung cancer.
Bychkov I; Deneka A; Topchu I; Pangeni R; Ismail A; Lengner C; Karanicolas J; Golemis E; Makhov P; Boumber Y
Res Sq; 2024 Apr; ():. PubMed ID: 38659828
[TBL] [Abstract][Full Text] [Related]
6. Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer.
Bychkov I; Topchu I; Makhov P; Kudinov A; Patel JD; Boumber Y
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173995
[TBL] [Abstract][Full Text] [Related]
7. Detection of a Novel
Ferrari A; Fiocca R; Bonora E; Domizio C; Fonzi E; Angeli D; Domenico Raulli G; Mattioli S; Martinelli G; Molinari C
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107676
[TBL] [Abstract][Full Text] [Related]
8. Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer.
Bychkov I; Topchu I; Makhov P; Kudinov A; Patel JD; Boumber Y
bioRxiv; 2023 Mar; ():. PubMed ID: 37034813
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysis.
Jiang L; Xue S; Xu J; Fu X; Wei J; Zhang C
Front Oncol; 2022; 12():969632. PubMed ID: 36530989
[TBL] [Abstract][Full Text] [Related]
10. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
11. The mechanisms and clinical significance of PDCD4 in colorectal cancer.
Long J; Yin Y; Guo H; Li S; Sun Y; Zeng C; Zhu W
Gene; 2019 Jan; 680():59-64. PubMed ID: 30243936
[TBL] [Abstract][Full Text] [Related]
12. Musashi 2 in hematopoiesis.
de Andrés-Aguayo L; Varas F; Graf T
Curr Opin Hematol; 2012 Jul; 19(4):268-72. PubMed ID: 22517588
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression.
Kharin L; Bychkov I; Karnaukhov N; Voloshin M; Fazliyeva R; Deneka A; Frantsiyants E; Kit O; Golemis E; Boumber Y
PLoS One; 2021; 16(7):e0252132. PubMed ID: 34237057
[TBL] [Abstract][Full Text] [Related]
14. Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC).
Topchu I; Karnaukhov N; Mazitova A; Yugai V; Voloshin M; Tikhomirova M; Kit O; Frantsiyants E; Kharin L; Airapetova T; Ratner E; Sabirov A; Abramova Z; Serebriiskii I; Boumber Y; Deneka A
J Thorac Dis; 2021 Mar; 13(3):1370-1379. PubMed ID: 33841930
[TBL] [Abstract][Full Text] [Related]
15. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
